Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

147.68
+11.068.10%
Volume:10.11M
Turnover:1.47B
Market Cap:58.96B
PE:-18.44
High:149.71
Open:138.09
Low:135.01
Close:136.62
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.71
T/O Rate:2.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.72
PE(LYR):-20.34

Loading ...

Movement Alert|Moderna, Inc. Rises 5.31% in Regular Trading, First mRNA Flu Vaccine Wins FDA Approval

Market Focus
·
Aug 07

Soligenix Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 07

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End

Reuters
·
Aug 07

U.S. Stocks on the MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International

Reuters
·
Aug 07

Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva

TIPRANKS
·
Aug 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future

Dow Jones
·
Aug 06

Pre-Market Outlook: US Index Futures Mixed; Memory Chip Stocks Slide on SanDisk and Western Digital Guidance Miss

Stock News
·
Aug 06

Novavax Lifts Annual Revenue Forecast as Licensing Bets Offset Weak Vaccine Demand

Reuters
·
Aug 06

U.S. Stocks on the MOVE-Cheniere Energy, TPG, Constellation Energy

Reuters
·
Aug 06

Roivant Q1 FY27 Net Loss Widens to $290.61 Million; Revenue Slips to $1.44 Million

Reuters
·
Aug 06

Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 06

Moderna Shares up 4% Premarket After US FDA Approval for Flu Vaccine

THOMSON REUTERS
·
Aug 06

Moderna Secures FDA Approval for First mRNA Flu Vaccine After Regulatory Hurdles, Commercial Prospects Remain Uncertain

Stock News
·
Aug 06

PRESS Digest -Wall Street Journal - August 6

Reuters
·
Aug 06

PRESS Digest-New York Times Business News - August 6

Reuters
·
Aug 06

US FDA Approves First mRNA Flu Shot from Moderna

Reuters
·
Aug 06

Moderna: Gets U.S. FDA Approval for Influenza Vaccine Mflusiva for Use in Adults 50 Years and Older

THOMSON REUTERS
·
Aug 06

Moderna: Expects Supply of Influenza Vaccine Mflusiva to be Available in Select Retailers in Coming Weeks

THOMSON REUTERS
·
Aug 06